BMS 6081 (Metaglip 2.5 mg / 250 mg)
Generic Name: glipizide/metformin
Pill with imprint BMS 6081 is Pink, Elliptical / Oval and has been identified as Metaglip 2.5 mg / 250 mg. It is supplied by Bristol-Myers Squibb.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 6081
More about Metaglip (glipizide / metformin)
- Metaglip Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: antidiabetic combinations
- FDA Alerts (1)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.